Retraction Note: Impact of the third wave of the COVID-19 pandemic and interventions to contain the virus on society and...
Published in Renal Replacement Therapy
Retraction Note: Impact of the third wave of the COVID-19 pandemic and interventions to contain the virus on society and...
Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19
Published in Renal Replacement Therapy
Background We experienced that some hemodialysis (HD) patients with coronavirus disease 2019 (COVID-19) exacerbated hypoxemia during HD. Though HD-induced hypoxemia has been reported, there have been no reports of HD-induced hypoxemia in patients with COVID-19 and its effect on prognosis of COVID-19. Methods Eleven HD patients admitted with COVID-1...
Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy.
...
Published in Renal replacement therapy
Patients with coronavirus disease 2019 (COVID-19) who receive dialysis therapy develop more severe disease and have a poorer prognosis than patients who do not. Although various data on the treatment of patients not receiving dialysis therapy have been reported, clinical practice for patients on dialysis is challenging as data is limited. The Infec...
Investigation of presenteeism, physical function, and exercise habits in workers with CKD: three case reports with liter...
Published in Renal replacement therapy
Management of presenteeism in the context of chronic kidney disease (CKD) is essential for disease management, ensuring the workforce's availability, and reducing health-related costs. The purpose of this case study was to investigate presenteeism, physical function, and exercise habits in three working patients with CKD and discuss their effects. ...
Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observatio...
Published in Renal replacement therapy
The mortality rate of novel coronaviral disease (COVID-19) patients undergoing dialysis is considerably higher than that of patients with normal kidney function. As of August 2021, only remdesivir has been approved in Japan as an antiviral drug for the treatment of COVID-19. However, in cases of kidney failure, remdesivir administration should be c...
Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage...
...
Published in Renal replacement therapy
Currently, it is unclear whether the progression of chronic kidney disease (CKD) could be an independent predictor of antibody response after administration of a COVID-19 vaccine. This study aimed to investigate the immune response to COVID-19 vaccination in patients with CKD stage G4 to G5 without renal replacement therapy and G5D using the recomm...
Low humoral immune response to the BNT162b2 vaccine against COVID-19 in nursing home residents undergoing hemodialysis: ...
Published in Renal Replacement Therapy
Background Patients on hemodialysis (HD) face a high mortality risk from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and they are therefore prioritized for vaccination. However, the efficacy of vaccination in this vulnerable population has not been confirmed. Although age is negativel...
Mechanical obstruction of the peritoneal catheter with ovarian fimbriae, case reports
Published in Renal Replacement Therapy
The number of treated patients with peritoneal dialysis accounts for 2.8% of all kidney replacement therapy methods and constantly decreases. Peritoneal dialysis should be the first choice as the kidney function replacement treatment method in a transplantation waiting period. Besides all other possible infectious and mechanical complications of pe...
Renal rehabilitation as a management strategy for physical frailty in CKD
Published in Renal Replacement Therapy
An aging population and the increasing prevalence of lifestyle-related diseases have led to a worldwide increase in the rate of chronic kidney disease requiring renal replacement therapy. The mean age of individuals requiring dialysis therapy has been increasing, and Japanese patients are aging more rapidly than those in the USA and Europe. Patient...
Assisted peritoneal dialysis: strategies and outcomes
Published in Renal Replacement Therapy
Assisted peritoneal dialysis (asPD) is a modality intended for not self-sufficient patients, mainly elderly, who are not able to perform peritoneal dialysis (PD) alone and require some help to manage the treatment. In the last decades, many countries developed strategies of asPD to face with aging of dialysis population and give an answer to the in...
